Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US45257L1089
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG002WD6SY6
IMMP
Immutep Limited
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Immutep Limited
ISIN
US45257L1089
TICKER
IMMP
MIC
XNAS
REUTERS
IMMP.OQ
BLOOMBERG
IMMP US
Sa., 25.04.2026       Immutep
US45257L1089

NEW YORK, April 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Do., 23.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 20.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 20.04.2026       Immutep
US45257L1089

NEW YORK, April 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Do., 16.04.2026       Immutep
US45257L1089

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 15.04.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, April 15, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Dat...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Di., 14.04.2026       Immutep
US45257L1089

NEW YORK, April 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Fr., 10.04.2026       Immutep
US45257L1089

NEW YORK, April 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations t...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Do., 09.04.2026       Immutep
US45257L1089

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 07.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WHA...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 06.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited (NASDAQ:IMMP) ("Immutep Limited") concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futilit...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Sa., 04.04.2026       Immutep
US45257L1089

NEW YORK, April 4, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Fr., 03.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep Ltd. may have issued materially misleading business information to the investing pub...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Do., 02.04.2026       Immutep
US45257L1089

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 01.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep Ltd. may have issued materially misleading business information to the investing public.S...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 01.04.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, April 1, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Data...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Immutep
US45257L1089

NEW YORK, March 30, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited ("Immutep Limited") (NASDAQ: IMMP) concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analys...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 30.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 26.03.2026       Immutep
US45257L1089

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 25.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 25.03.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, March 25, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Dat...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Di., 24.03.2026       Immutep
US45257L1089

NEW YORK, March 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from al...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 23.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited (NASDAQ: IMMP) ("Immutep Limited") concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futil...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 23.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Sa., 21.03.2026       Immutep
US45257L1089

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disc...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Do., 19.03.2026       Immutep
US45257L1089

NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Immutep
US45257L1089

Immutep Reported TACTI-004 Futility Analysis Was "On Track" in January 2026 -- Weeks Later the Trial Was Halted After Failing to Meet Efficacy EndpointsNEW YORK, March 18, 2026 /PRNewswire/ -- Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the fut...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Immutep
US45257L1089

NEW YORK, March 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from al...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Immutep
US45257L1089

Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public. So What: If you purchased Immutep securities yo...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited ("Immutep Limited") (NASDAQ: IMMP) concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analys...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Immutep
US45257L1089

Instrument ID [8545] (YP1A - US45257L1089) suspended...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink
Mo., 03.06.2024       Immutep
US45257L1089

Instrument ID [8545] (YP1A - US45257L1089) suspended...
Zur Nachricht
Immutep
Charts & Research Termsheets Terminal
Permalink